ACADIA Pharmaceuticals Inc (ACAD)

19.94
+1.04(+5.50%)
After Hours
19.54
-0.40(-2.01%)
- Real-time Data
  • Volume:
    1,078,496
  • Bid/Ask:
    19.51/20.00
  • Day's Range:
    18.75 - 19.99

ACAD Overview

Prev. Close
18.9
Day's Range
18.75-19.99
Revenue
474.39M
Open
18.9
52 wk Range
15.68-57.26
EPS
-1.2
Volume
1,078,496
Market Cap
3.21B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,239,938
P/E Ratio
-
Beta
0.56
1-Year Change
-63.57%
Shares Outstanding
160,755,971
Next Earnings Date
Mar 01, 2022
What is your sentiment on ACADIA Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

ACADIA Pharmaceuticals Inc Company Profile

Employees
570

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis; Trofinetide, a novel synthetic analog for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor for treating cognition and schizophrenia. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyNeutralStrong Sell
SummaryStrong BuyStrong BuyStrong BuyBuyStrong Sell
  • what is going on
    0
    • Thuyii78857ujuuoukho0ojmBnmnmnBjjkjkBnjkh
      1
      • eh il wait til we trading above bollinger band to short, much safer
        3
        • woops wrong board
          0
      • slow ride to the moon but worth the wait
        0
        • going to the moon
          0
          • get back to 50 please
            1
            • 4197 close imo
              0
              • A italian journalist predict a new clinical trail for the sustrate. This will take time i suppose.
                0
                • Somebody knows something.
                  0
                  • https://www.trefis.com/stock/acad/articles/510930/acadia-pharmaceuticals-stock-now-looks-oversold-at-27-levels/2021-03-15
                    1
                    • Lowest downgrade is 27usd do...it can,t be that wrong.
                      0
                      • Paperhands are out.
                        0
                        • 30 next week
                          0
                          • 26
                            0
                            • Ok, some aftermarket
                              0
                              • I am guessing this will fly in the aftermarket.
                                0
                                • Why this stock is so down?
                                  0
                                  • Today its go more dwon
                                    0
                                    • Who knows it's green now but
                                      0
                                  • So I don't follow highly paid analysts' recommendations, they have their own business in it.
                                    0
                                    • Is it good to buy at 25$?
                                      0
                                    • Jobir Avezov  Yes, but don't be hurry, the time will come.
                                      0
                                    • Thank you
                                      0
                                  • Seems to have stalled. Is something happening
                                    0
                                    • here it'll be good
                                      0
                                      • Buy, 2021 will be great
                                        1
                                        • ACAD is a buy, we should see 5% higher next week.
                                          0
                                          • falling
                                            0
                                            • Let's see where it's go from here
                                              0
                                              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.